1067221-97-9 Usage
Uses
Used in Pharmaceutical Industry:
(4R)-3-[(2E)-2-methyl-1-oxo-1-buten-1-yl]-4-(phenylmethyl)-2-oxazolidinone is used as a potential pharmaceutical compound for its unique molecular structure, which may offer novel therapeutic properties. The chiral nature of the molecule could provide specific interactions with biological targets, making it a candidate for drug development.
Used in Organic Synthesis:
In the field of organic synthesis, (4R)-3-[(2E)-2-methyl-1-oxo-1-buten-1-yl]-4-(phenylmethyl)-2-oxazolidinone serves as a valuable building block. Its distinct structural features can be utilized in the creation of more complex organic molecules, potentially leading to new materials or advanced chemical entities.
Further research and testing are necessary to explore the specific uses and potential applications of (4R)-3-[(2E)-2-methyl-1-oxo-1-buten-1-yl]-4-(phenylmethyl)-2-oxazolidinone across different industries. Its unique structure and chiral configuration present opportunities for innovation and development in both pharmaceutical and chemical synthesis domains.
Check Digit Verification of cas no
The CAS Registry Mumber 1067221-97-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,7,2,2 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1067221-97:
(9*1)+(8*0)+(7*6)+(6*7)+(5*2)+(4*2)+(3*1)+(2*9)+(1*7)=139
139 % 10 = 9
So 1067221-97-9 is a valid CAS Registry Number.
1067221-97-9Relevant academic research and scientific papers
Synthesis and biological activity of enantiomeric pairs of 5-(alk-2-enyl)thiolactomycin and 5-[(E)-cycloalk-2-enylidenemethyl] thiolactomycin congeners
Ohata, Kohei,Terashima, Shiro
experimental part, p. 920 - 936 (2010/03/23)
The title compounds were synthesized by the efficient route previously explored for the synthesis of enantiomeric pairs of thiolactomycin and its 3-demethyl derivative. These studies were carried out to prove the flexibility of the previously explored synthetic route to natural thiolactomycin (TLM) 1 and to examine the structure-activity relationship on the 5-position of 1. While all of the synthesized congeners lacked in vitro antibacterial activity, these studies led us to find 5-(alk-2-enyl)-TLM (ent-4d) which exhibits mammalian type I fatty acid synthase (FAS) inhibitory activity equal to that of C75, a potent inhibitor reported previously. It was also found that 5-[(E)-cycloalk-2- enylidenemethyl]-TLM (ent-5c) exhibited slightly less potent mammalian type I FAS inhibitory activity than C75.
Synthesis and biological activity of enantiomeric pairs of 5-vinylthiolactomycin congeners
Ohata, Kohei,Terashima, Shiro
, p. 4070 - 4074 (2008/02/07)
Twelve enantiomeric pairs of 5-vinylthiolactomycin congeners were synthesized by employing our efficient synthetic route previously explored for the synthesis of enantiomeric pairs of thiolactomycin and its 3-demethyl derivative. From the biological activ
